These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 225904)

  • 41. Determination of calcium phosphate inhibitor activity. Critical assessment of the methodology.
    Meyer JL; Fleisch H
    Miner Electrolyte Metab; 1984; 10(4):249-58. PubMed ID: 6087103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystallographic investigations of urinary calcium oxalate calculi.
    Schubert G; Brien G
    Int Urol Nephrol; 1981; 13(3):249-60. PubMed ID: 7327899
    [No Abstract]   [Full Text] [Related]  

  • 43. [High molecular weight substances which inhibit calcium oxalate crystal growth. 1: Relative potencies of various kinds of urinary inhibitors which were determined new assay method (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1334-41. PubMed ID: 215812
    [No Abstract]   [Full Text] [Related]  

  • 44. [Measurements of urinary macromolecular inhibitory activity of calcium oxalate crystal aggregation].
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):644-51. PubMed ID: 7176279
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of inhibitors on the crystal growth of calcium oxalate.
    Minero C; Maggiorotti P; Barbeni M; Pelizzetti E; Tizzani A; Casetta G; Piana P; Giona C
    Contrib Nephrol; 1987; 58():65-72. PubMed ID: 3691149
    [No Abstract]   [Full Text] [Related]  

  • 46. A gel model for measuring crystallization inhibitor activities.
    Schneider HJ; Bothor W; Berg W; Börner RH; Jakob M
    Urol Int; 1983; 38(1):33-8. PubMed ID: 6836779
    [No Abstract]   [Full Text] [Related]  

  • 47. The characteristics of adsorption of pyrophosphate and citrate onto whewellite.
    Wagner M; Finlayson B
    Invest Urol; 1978 May; 15(6):456-8. PubMed ID: 206522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of magnesium in calcium lithiasis].
    Bataille P; Fournier A
    Presse Med; 1988 Feb; 17(7):301-3. PubMed ID: 2966347
    [No Abstract]   [Full Text] [Related]  

  • 49. EFFECT OF ORAL PYRO- AND TRIPOLYPHOSPHATE ON RAT UROLITHIASIS.
    GILL WB; VERMEULEN CW
    Invest Urol; 1965 Mar; 2():485-90. PubMed ID: 14261790
    [No Abstract]   [Full Text] [Related]  

  • 50. "Boiler crud" in urinary pipes.
    Howard JE
    N Engl J Med; 1972 Mar; 286(9):485-6. PubMed ID: 5009749
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characterization of urinary macromolecular inhibitors of calcium oxalate crystal aggregation].
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):652-7. PubMed ID: 6184514
    [No Abstract]   [Full Text] [Related]  

  • 52. [Physicochemical aspects of urinary lithiasis].
    Lundager Madsen HE
    Nephrologie; 1984; 5(4):151-4. PubMed ID: 6527716
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on dentinogenesis in the rat. Light, electron microscopic and histochemical studies on the interaction between lead pyrophosphate solutions and dentin-producing tissues.
    Larsson A; Helander HF
    Calcif Tissue Res; 1974; 14(2):87-104. PubMed ID: 4132184
    [No Abstract]   [Full Text] [Related]  

  • 54. Scanning electron microscopic studies of the ultrastructure of Jack stone calculi.
    Rao MV; Agarwal JS; Chhotray N
    Indian J Med Res; 1983 Feb; 77():288-94. PubMed ID: 6222969
    [No Abstract]   [Full Text] [Related]  

  • 55. [Value of the metabolic study of patients presenting renal calculosis of calcifications. Note on the metabolic effect of heparin and sodium citrate].
    VERBANCK M; TOPPET N; KAHN R
    Acta Clin Belg; 1959; 14():519-51. PubMed ID: 13841726
    [No Abstract]   [Full Text] [Related]  

  • 56. New in vitro methodological approaches to GAG study in idiopathic calcium lithiasis.
    Caudarella R; Simonelli L; Vasi V; Rizzoli E; Malavolta N; Stefani F; Cappelletti R
    Contrib Nephrol; 1987; 58():89-92. PubMed ID: 3691155
    [No Abstract]   [Full Text] [Related]  

  • 57. Antagonists of bacitracin.
    Podlesek Z; Comino A
    Lett Appl Microbiol; 1994 Aug; 19(2):102-4. PubMed ID: 7765220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An assay method for the measurement of urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM
    Clin Chim Acta; 1978 Oct; 89(2):256-72. PubMed ID: 213212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of genesis and growth of calculi.
    Vermeulen CW; Lyon ES
    Am J Med; 1968 Nov; 45(5):684-92. PubMed ID: 4879831
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of additivity in the context of a Langmuir inhibitor adsorption process.
    Finlayson B
    J Urol; 1982 Apr; 127(4):816-7. PubMed ID: 7069863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.